Immediate Infusion Reaction to Intravenous Risankizumab-rzaa but Subsequent Tolerance to Subcutaneous Risankizumab-rzaa
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Risankizumab-rzaa (RZA), a biologic therapy, can be safely switched to a subcutaneous formulation after a severe infusion reaction to the intravenous version. This transition demonstrates a viable option for patients experiencing hypersensitivity to IV RZA.
Area Of Science
- Immunology
- Pharmacology
- Dermatology
Background
- Risankizumab-rzaa (RZA) is a fully human IgG monoclonal antibody (Mab) targeting IL-23.
- RZA is approved for moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease.
- Pivotal trials indicated no significant difference in infusion reactions between RZA and placebo.
Observation
- A patient experienced a serious hypersensitivity reaction to intravenous (IV) RZA.
- The patient was successfully transitioned to subcutaneous (SC) RZA.
- No further adverse events were noted after the switch to SC administration.
Findings
- Successful transition from IV to SC RZA is feasible in patients with hypersensitivity.
- Subcutaneous administration may mitigate risks associated with IV infusions.
- Individual patient responses to biologic therapies can necessitate formulation adjustments.
Implications
- This case highlights a potential management strategy for patients experiencing infusion reactions to IV biologics.
- Subcutaneous RZA offers a potentially safer alternative for hypersensitive individuals.
- Further research may explore the long-term safety and efficacy of SC RZA in this patient population.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Overview
We speak of an allergy when the immune system triggers a response against a benign foreign structure, like food, pollen or pet dander. These elicitors are called allergens. If the immune system of a hypersensitive individual was primed against a specific allergen, it will trigger allergic symptoms during every subsequent encounter of the allergen. Symptoms can be mild, such as hay fever, to severe, such as potentially fatal anaphylactic shock.
Sensitization Is the First Step of an...
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
Overview
The ability of a single antibody to recognize multiple structurally similar epitopes is an important immune defense strategy that enables the host to efficiently defend against many potentially threatening pathogens. However, cross-reactivity also elicits allergy symptoms against related allergens. It is increasingly important to understand the principles of cross-reactivity, as antibodies are actively being developed as therapeutic modalities for diverse diseases, including cancer.
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...